Navigation Links
Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
Date:10/12/2007

Bridgewater, NJ, October 12, 2007 -- Excerpta Medica, an Elsevier business that has delivered medical communications for over six decades, has merged with corporate sibling Elsevier Interactive Solutions (EIS), an award-winning interactive health communications agency with more than a decades experience creating online marketing and educational programs for leading healthcare brands. Excerpta Medica will now be able to offer customers in the pharmaceutical and biotechnology industries a full range of comprehensive, turn-key communication solutions that combine important and timely clinical content with innovative online tools.

As the online channel becomes increasingly important to our clients, we can now provide them with seamless access to a proven pioneer in interactive health care marketing, says Greg Samios, President of Excerpta Medica. Health care organizations now have a choice: juggle work amongst several agencies for integrated campaigns, or work with us and benefit from the time- and cost-savings of having all the services they need in one organization.

To reflect the merger, EIS has changed its name to Excerpta Medica Interactive (http://www.ExMInteractive.com/) and will operate as a division of Excerpta Medica. Excerpta Medica Interactive will service clients globally from its offices in Toronto.


'/>"/>

Contact: Scott Breed
s.breed@elsevier.com
908-547-2130
Elsevier
Source:Eurekalert

Page: 1

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. What happens when Medications go wrong?
3. Teens turning to Internet for medical queries
4. Medicare Drug Deadline not to be extended
5. Medications to Prevent Relapse to Cocaine Use
6. More Elderly Take Inappropriate and Harmful Medications
7. Medications for depression
8. Robots craft medical history
9. NBE to conduct test for medical students from abroad
10. Medications linked to xerostomia and caries
11. Medication recuperates fat distribution in diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a hot ... suggests that Americans prefer their dogs straight off the grill. Of the 90 percent ... favorite way to cook a hot dog, far outpacing other cooking methods such as ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... ... MadgeTech will be showcasing its line of data logging products , ... MadgeTech headquarters. With products sold in more than 100 countries around the world, MadgeTech ... , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data loggers around ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the ... Insurance is sharing tips to make sure your family and vehicle are ready ... Safety Council, there may be 439 deaths and an additional 50,500 serious injuries from ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
Breaking Medicine Technology: